| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/23/2013 | WO2013073219A1 Method for producing insoluble aggregate of neurodegenerative-disease-related protein |
| 05/23/2013 | WO2013073041A1 Method for determining rheumatoid arthritis activity indicator, and biomarker used therein |
| 05/23/2013 | WO2013072877A1 Particle repulsion to enhance surface contact in magnetic particle immunoassays |
| 05/23/2013 | WO2013072585A1 Method for characterizing circulating tumor cells, and use thereof in diagnosis |
| 05/23/2013 | WO2013072572A1 Method for characterising circulating tumour cells and application to diagnostics |
| 05/23/2013 | WO2013072515A1 Nucleic acid production and sequence analysis |
| 05/23/2013 | WO2013072494A1 Method for detecting the presence of expanded spectrum b-lactamase-producing bacteria in a sample |
| 05/23/2013 | WO2013072465A1 Dual gene expression signature to predict clinical outcome and therapeutic response of a patient affected with a cancer |
| 05/23/2013 | WO2013072408A1 Surface-functionalized cellulosic fibres, method of manufacture thereof and uses thereof |
| 05/23/2013 | WO2013072346A2 Discrete states for use as biomarkers for cancers such as renal cell cancer |
| 05/23/2013 | WO2013072069A1 Method for performing quantitation assays |
| 05/23/2013 | WO2013071954A1 Streptococcus pneumoniae detection in blood |
| 05/23/2013 | WO2013071876A1 Constructing method of high-throughput sequencing library and use thereof |
| 05/23/2013 | WO2013071520A1 Method and system of virus detection |
| 05/23/2013 | WO2013071502A1 Mir-193a-3p and associated genes predict tumorigenesis and chemotherapy outcomes |
| 05/23/2013 | WO2013071450A1 A method for assaying the activity of spermidine/spermine n1-acetyltrasferase |
| 05/23/2013 | WO2013071415A1 Targeting the rb pathway for the prevention of cancer |
| 05/23/2013 | WO2013071410A1 Biomarkers for t cell malignancies and uses thereof |
| 05/23/2013 | WO2013071365A1 A method of treatment and prophylaxis and compositions useful therefor |
| 05/23/2013 | WO2013049831A3 Oxygenase-based biosensing systems for measurement of halogenated alkene concentrations |
| 05/23/2013 | WO2013049782A3 System, apparatus and method for evaluating samples or analytes using a point-of-care device |
| 05/23/2013 | WO2013049564A3 Ultra-rapid diagnostic tissue preparation as an alternative to frozen section |
| 05/23/2013 | WO2013048163A3 Convenient and efficient purification method for chemically labeled nucleic acids |
| 05/23/2013 | WO2013048087A3 Composition of redox-reagents for electrochemical biosensor and biosensor comprising the same |
| 05/23/2013 | WO2013042960A3 Method for preparing microvesicular adam15 |
| 05/23/2013 | WO2013025261A3 Fluorogenic peptide probes and assays |
| 05/23/2013 | WO2013024267A3 Stabilized compositions against ionising radiation |
| 05/23/2013 | WO2013005107A3 Method for predicting response or prognosis of lung adenocarcinoma with egfr-activating mutations |
| 05/23/2013 | WO2012159121A3 Microbe detection via hybridizing magnetic relaxation nanosensors |
| 05/23/2013 | WO2012067830A3 Methylation assay |
| 05/23/2013 | WO2012061157A8 Method for high-throughput identification of microbial antagonists against pathogens |
| 05/23/2013 | WO2011097540A9 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 05/23/2013 | US20130133106 Isolated polynucleotides and methods and plants using same for regulating plant acidity |
| 05/23/2013 | US20130131329 Methods and compositions for detecting gastrointestinal and other cancers |
| 05/23/2013 | US20130131195 c-Src Selected Reaction Monitoring Assay |
| 05/23/2013 | US20130131194 Use of microvesicles in diagnosis and prognosis of medical diseases and conditions |
| 05/23/2013 | US20130131153 Cullin 5 as a regulator of hsp90 clients: a new target for drug development |
| 05/23/2013 | US20130131148 Micro-rna for cancer diagnosis, prognosis and therapy |
| 05/23/2013 | US20130131146 Compositions and Methods for Treating Pulmonary Conditions |
| 05/23/2013 | US20130131144 GDE Compositions and Methods |
| 05/23/2013 | US20130131140 Treatment of diabetes and disorders associated with visceral obesity with inhibitors of human arachidonate 12 lipoxygenase and arachidonate 15-lipoxygenase |
| 05/23/2013 | US20130131139 Ror1 as a gene target in acute lymphoblastic leukemia |
| 05/23/2013 | US20130131136 Novel methods for predicting the responsiveness of a patient affected with a tumor to a treatment with a tyrosine kinase inhibitor |
| 05/23/2013 | US20130131072 Methods for Optimizing Clinical Responsiveness to Methotrexate Therapy Using Metabolite Profiling and Pharmacogenetics |
| 05/23/2013 | US20130130966 Method of determining the metastatic potential of a tumor |
| 05/23/2013 | US20130130965 Method to detect and treat infectious or inflammatory diarrhea based on reg1 |
| 05/23/2013 | US20130130937 Sample holder for microarray reader based on evanescent wave biosensor |
| 05/23/2013 | US20130130934 Efficient high-throughput screen for identifying novel chemical compounds which disrupt the fungal vacuole |
| 05/23/2013 | US20130130931 Biomarker for the diagnosis, prognosis and monitoring of cancer |
| 05/23/2013 | US20130130930 Methods and devices for obtaining and analyzing cells |
| 05/23/2013 | US20130130929 Methods, devices, and kits for obtaining and analyzing cells |
| 05/23/2013 | US20130130928 Methods for predicting or monitoring whether a patient affected by a cancer is responsive to a treatment with a molecule of the taxoid family |
| 05/23/2013 | US20130130927 Detection and quantification of micrornas in the circulation and the use of circulating micrornas as biomarkers for cancer |
| 05/23/2013 | US20130130924 Method for analyzing d4z4 tandem repeat arrays of nucleic acid and kit therefore |
| 05/23/2013 | US20130130923 Processes and kits for identifying aneuploidy |
| 05/23/2013 | US20130130921 Kit, a Device and a Method for Detecting Copy Number of Fetal Chromosomes or Tumor Cell Chromosomes |
| 05/23/2013 | US20130130920 High through-put analysis of transgene borders |
| 05/23/2013 | US20130130919 Long-Range Barcode Labeling-Sequencing |
| 05/23/2013 | US20130130918 Exercise genotyping |
| 05/23/2013 | US20130130917 Method for specific enrichment of nucleic acid sequences |
| 05/23/2013 | US20130130397 Compositions and methods for simultaneous detection of volatile sulfur compounds and polyamines |
| 05/23/2013 | US20130130388 Methods of Modifying Eurakyotic Cells |
| 05/23/2013 | US20130130369 System and method including analytical units |
| 05/23/2013 | US20130130368 Integrated microbial collector |
| 05/23/2013 | US20130130365 Devices |
| 05/23/2013 | US20130130360 Apparatus and methods for manipulation and optimization of biological systems |
| 05/23/2013 | US20130130354 Novel genes and uses thereof, expression profile of colon, gastric and pancreatic cancer |
| 05/23/2013 | US20130130311 Methods and systems for assessing clonality of cell cultures |
| 05/23/2013 | US20130130310 Absorbent paper and use thereof for breast cancer detection |
| 05/23/2013 | US20130130308 Process for directly measuring multiple biodegradabilities |
| 05/23/2013 | US20130130307 Cell observation device and cell observation method |
| 05/23/2013 | US20130130305 Indentifying antifungal agents that inhibit iaa or a yap family |
| 05/23/2013 | US20130130304 Methods for screening microbial growth inhibition activity on materials |
| 05/23/2013 | US20130130303 Methods for screening microbial remediation agents |
| 05/23/2013 | US20130130302 Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of dna |
| 05/23/2013 | US20130130301 Microfluidic platform for discrete cell assay |
| 05/23/2013 | US20130130300 Method and apparatus for the non-invasive monitoring of gas exchange by biological material |
| 05/23/2013 | US20130130299 Electrochemical flow cytometry |
| 05/23/2013 | US20130130298 Blood product management method using rbc deformability-based metrics |
| 05/23/2013 | US20130130294 Novel method for characterizing and multi-dimensionally representing the folding process of proteins |
| 05/23/2013 | US20130130291 Labelling of Fusion Proteins with Synthetic Probes |
| 05/23/2013 | US20130130290 Distinguishing cells in a sample by inactivating extracellular enzyme before releasing intracellular enzyme |
| 05/23/2013 | US20130130283 Methods for Identifying Inhibitors of the Type III Secretion System |
| 05/23/2013 | US20130130273 Method for detecting interactions between two and more biological macromolecules |
| 05/23/2013 | US20130130271 Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of dna |
| 05/23/2013 | US20130130270 Filtration methods and devices |
| 05/23/2013 | US20130130269 Screening tool for anti-inflammatory drug discovery comprising the fpr2/alx gene promoter |
| 05/23/2013 | US20130130266 Methods and devices for obtaining and analyzing cells |
| 05/23/2013 | US20130130265 Methods and devices for obtaining and analyzing cells |
| 05/23/2013 | US20130130264 Methods of Detecting BRAF Mutations in Cancer |
| 05/23/2013 | US20130130259 Methods for evaluating the methylation status of a polynucleotide |
| 05/23/2013 | US20130130258 Detection, identification and differentiation of eubacterial taxa using a hybridization assay |
| 05/23/2013 | US20130130257 Mobile rapid test system for nucleic acid analysis |
| 05/23/2013 | US20130130256 Acf detection method |
| 05/23/2013 | US20130130253 Metronidazole resistance in trichomonas vaginalis and single nucleotide polymorphisms |
| 05/23/2013 | US20130130252 Identification of pold2 sequences |
| 05/23/2013 | US20130130251 Identification of snare ykt6 sequences |
| 05/23/2013 | US20130130250 Isolated glucokinase genomic polynucleotide fragments from chromosome 7 |
| 05/23/2013 | US20130130249 Nucleic acid production and sequence analysis |
| 05/23/2013 | US20130130248 Endoribonuclease compositions and methods of use thereof |